Status:
UNKNOWN
Gastric Cancer Metastasized to the Central Nervous System (CNS)
Lead Sponsor:
University of Zurich
Conditions:
Gastric Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Descriptive registry to investigate frequency of HER-2 positive gastric cancer involving CNS. Exploration of additional prognostic factors for brain involvement from gastric cancer.
Detailed Description
HER2 Status E-Cadherin Status
Eligibility Criteria
Inclusion
- Inclusion criteria:
- in order to be eligible for the study, the diagnosis of gastric cancer and/or lower esophageal cancer must be confirmed histologically. CNS involvement must be confirmed either via independent neuroradiological and/or positive CSF cytology.
- Exclusion criteria:
- Patients whose diagnosis is not confirmed upon pathological review or where the CNS involvement cannot be confirmed after neuroradiological review will be excluded from this study.
Exclusion
Key Trial Info
Start Date :
August 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2020
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01456455
Start Date
August 1 2011
End Date
August 1 2020
Last Update
October 25 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept Oncology, University Hospital Zürich
Zurich, Switzerland, 8091